netFormulary Harrogate & Rural District Formulary NHS
Harrogate & District NHS Foundation Trust
Harrogate & Rural District Clinical Commissioning Group
 
 
 Search
 Results

Looking for Adalimumab found 15 matches

Formulary BNF Category
  Restricted Drug  Adalimumab  (Humira) Drugs affecting the immune response - 13.05.03
  Restricted Drug  Adalimumab  (Humira) Cytokine inhibitors - 01.05.03
  Restricted Drug  Adalimumab  (Humira) Drugs affecting the immune response - 10.01.03
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section - TA455 - Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (10.01.03)
link in drug section - TA455 - Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA329: Infliximab, adalimumab and golimumab for moderately to severely active ulcerative colitis  (01.05.03)
link in drug section NICE TA329: Infliximab, adalimumab and golimumab for treating moderately to severeley active ulcerative colitis after failure of conventional therapy (01.05.03)
link in drug section NICE TA329: Infliximab, adalimumab and golimumab for treating moderately to severeley active ulcerative colitis after failure of conventional therapy (01.05.03)
link in drug section NICE TA455 - Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (10.01.03)
link in drug section NICE TA455 Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA455 Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA455 Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA460 Adalimumab and dexamethasone for treating non-infectious uveitis (11.04.02)
link in drug section TA455 - Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (10.01.03)
link in drug section TA455 - Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (01.05.03)


 

netFormulary